Related Experiment Video
Updated: Jun 18, 2026
09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
Induced pluripotent stem cell therapies for retinal disease
Oliver Comyn1, Edward Lee, Robert E MacLaren
1Sussex Eye Hospital, Brighton, UK.
Current Opinion in Neurology
|December 2, 2009
Summary
Induced pluripotent stem (iPS) cells are advancing stem cell biology toward clinical applications for retinal degeneration. Optimized reprogramming methods enhance safety, bringing therapies closer to patients.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Ophthalmology
Background:
- Induced pluripotent stem (iPS) cells offer a pathway to clinical applications in retinal degeneration.
- Advances in reprogramming techniques have improved the safety and efficiency of iPS cell generation.
Purpose of the Study:
- To review recent advances in induced pluripotent stem (iPS) cell technology.
- To discuss the potential of iPS cells for clinical applications in retinal degeneration.
Main Methods:
- Review of recent scientific literature on iPS cell generation and application.
- Discussion of reprogramming methods, including optimization to avoid retroviruses.
- Analysis of the suitability of the retina for stem cell therapies.
Main Results:
- Adult cells can be reprogrammed directly into iPS cells without a surrogate oocyte.
- Optimized reprogramming methods enhance the safety of iPS cell generation.
- Human iPS cells have been successfully differentiated into neurons in vitro.
Conclusions:
- The retina presents an ideal target for stem cell therapies due to accessibility and direct observation.
- Further research is needed to identify the most appropriate retinal diseases for iPS cell clinical trials.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...